01—Abstract
Summary
Summary of the 10-K filed February 25, 2019. Cited figures are marked; the original filing is the authoritative source.
Tempur Sealy International, Inc. (filed under this name; now Somnigroup International) reported 2018 net sales of $2.70 billiona, essentially flat versus $2.70 billion in 2017 (up 0.1%, or down 0.3% on a constant currency basis).
Gross margin was 41.5% in both years, but operating income fell to $256.3 millionb from $295.5 million, and GAAP net income attributable to the company declined to $100.5 million from $151.4 million, or $1.82 per diluted share versus $2.77. Adjusted EBITDA was $424.7 million versus $445.6 million. Management attributes the 2018 pressure to the phased U.S. rollout of new Tempur products, which brought launch costs, cannibalization of higher-priced products, and a delay to ensure product quality, along with customer bankruptcies that produced $31.3 million of bad debt expense.
Leverage and capital allocation were key themes. Total debt was $1,653.8 millionc at year-end 2018, and the ratio of consolidated funded debt less qualified cash to adjusted EBITDA was 3.87 times, within the 5.00 times covenant limit. The company made no share repurchases in 2018 and had approximately $226.9 million remaining under its authorization.
It also divested certain Latin American subsidiaries, which are presented as discontinued operations, and it resolved the long-running Danish Tax Matter with SKAT and the IRS for the 2001 through 2011 settlement years, while maintaining an uncertain tax liability for later years under an advance pricing agreement program. Looking ahead, the filing expects gross margin to benefit in 2019 from Tempur sales growth, pricing actions of approximately $30 milliond, and improved merchandising mix, partly offset by a slight decline in Sealy sales in North America. It also flags a customer bankruptcy (Innovative Mattress Solutions, LLC) for which the company submitted a stalking horse bid of up to $26 million, and expects foreign exchange translation to reduce 2019 net sales by approximately $30 million.
02—Key points
Key Highlights
- Net sales were $2,702.9 million in 2018, up 0.1% from $2,700.6 million in 2017; North America net sales decreased $37.6 million, or 1.7%, while International net sales increased $39.9 million, or 7.6%.
- GAAP operating income fell to $256.3 million (9.5% of net sales) from $295.5 million (10.9%); adjusted operating income was $307.6 million (11.4%) versus $325.3 million (12.0%).
- GAAP diluted EPS was $1.82 versus $2.77 in 2017; adjusted EPS was $2.96 versus $3.28.
- Adjusted EBITDA was $424.7 million, down 4.7% from $445.6 million; the leverage ratio of 3.87 times was within the 5.00 times covenant limit.
- Total debt was $1,653.8 million at December 31, 2018, and the company made no share repurchases during 2018, with $226.9 million remaining under the authorization.
- The Danish Tax Matter was settled with SKAT and the IRS for tax years 2001 through 2011, while an advance pricing agreement program covers tax years 2012 through 2022.
- A customer, Innovative Mattress Solutions, LLC, filed for Chapter 11 on January 11, 2019; the company submitted a stalking horse bid for its assets with a purchase price expected to be up to $26 million.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2018, Somnigroup International kept $0.04.
- Revenue$2.70B100.0%
- Cost of revenue−$1.58B58.5%
- Gross profit$1.12B41.5%
- Operating costs−$864.4M32.0%
- Operating income$256.3M9.5%
- Interest, other & tax−$155.8M5.8%
- Net income$100.5M3.7%
Where FY2018 revenue went
$2.70B- Cost of revenue: $1.58B, 59% of revenue
- Other operating costs: $842.5M, 31% of revenue
- Net income: $100.5M, 3.7% of revenue
- R&D: $21.9M, 0.8% of revenue
- Interest, other & tax: $155.8M, 5.8% of revenue
Kept 3.7% as net incomeNet income $100.5M · 3.7%R&D $21.9M · 0.8%
Full revenue history →04—Financials
Financial Highlights
Figures from 10-KFY2018filed February 25, 2019Financial Statements
FY2018 against FY2017
| Line item | FY2018FY2017 | Change |
|---|---|---|
| Revenue | $2.70B$2.70B | +0.1% |
| Cost of Revenue | $1.58B$1.58B | +0.2% |
| Gross Profit | $1.12B$1.12B | 0.0% |
| R&D Expenses | $21.90M$21.70M | +0.9% |
| Operating Income | $256.30M$295.50M | −13.3% |
| Interest Expense | $92.30M$87.30M | +5.7% |
| Net Income | $100.50M$151.40M | −33.6% |
| EPS (Basic) | $0.46$2.80 | −83.6% |
| EPS (Diluted) | $0.46$2.77 | −83.4% |
| Shares Outstanding (Basic) | 217.60M54.00M | +303.0% |
| Shares Outstanding (Diluted) | 220.40M54.70M | +302.9% |
05—Questions
Frequently Asked Questions
Why did profitability decline in 2018 despite flat net sales?
The filing attributes the decline to the phased rollout of new Tempur products, which brought incremental launch costs, cannibalization of higher-priced Tempur products, and a temporary delay to ensure product quality. Gross margin was flat at 41.5%, but operating expenses rose, including $31.3 million of bad debt expense tied to customer bankruptcies, and North America operating income fell $23.2 million.
How is the company's debt position and leverage?
Total debt was $1,653.8 million at December 31, 2018, down from $1,762.5 million a year earlier. The ratio of consolidated funded debt less qualified cash to adjusted EBITDA was 3.87 times, within the covenant limit of 5.00 times, and management's target range is 3.0 to 4.0 times with a midpoint of 3.5 times. The company expects to continue using excess cash flow for debt repayment.
Why did the company not repurchase shares in 2018?
The filing states that the company made no share repurchases during 2018 under its program, which had approximately $226.9 million remaining as of December 31, 2018. Repurchases are subject to market conditions and restrictions in the company's debt agreements, and the filing notes that repurchases could diminish cash reserves.
What are the main risks to 2019 results mentioned in the filing?
Key risks include the uncertain outcome of the Danish Tax Matter if the IRS and SKAT do not reach agreement on the APA Program years, the pending U.S. Department of Commerce anti-dumping investigation into Chinese mattress imports with a preliminary determination expected in May 2019, the iMS bankruptcy and the outcome of the Section 363 auction, expected foreign exchange headwinds of approximately $30 million in net sales, and the success of the Tempur product launch.
06—Continue